These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38757478)

  • 21. Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds.
    Zuccolo M; Arrighetti N; Perego P; Colombo D
    Curr Med Chem; 2022; 29(15):2566-2601. PubMed ID: 34365939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review).
    Chaney S
    Int J Oncol; 1995 Jun; 6(6):1291-305. PubMed ID: 21556672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platinum speciation used for elucidating activation or inhibition of Pt-containing anti-cancer drugs.
    Michalke B
    J Trace Elem Med Biol; 2010 Apr; 24(2):69-77. PubMed ID: 20413063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.
    Jurgens S; Kuhn FE; Casini A
    Curr Med Chem; 2018 Feb; 25(4):437-461. PubMed ID: 28554319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy.
    Han X; Sun J; Wang Y; He Z
    Med Res Rev; 2015 Nov; 35(6):1268-99. PubMed ID: 26280923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancements in the Use of Platinum Complexes as Anticancer Agents.
    Sharma R; Singh VJ; Chawla PA
    Anticancer Agents Med Chem; 2022; 22(5):821-835. PubMed ID: 34353272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metal-based anticancer chemotherapeutic agents.
    Muhammad N; Guo Z
    Curr Opin Chem Biol; 2014 Apr; 19():144-53. PubMed ID: 24608084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Developments in the Field of Tumor-Inhibiting Metal Complexes.
    Galanski MS; Arion VB; Jakupec MA; Keppler BK
    Curr Pharm Des; 2003; 9(25):2078-89. PubMed ID: 14529417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can an Elusive Platinum(III) Oxidation State be Exposed in an Isolated Complex?
    Corinti D; Frison G; Chiavarino B; Gabano E; Osella D; Crestoni ME; Fornarini S
    Angew Chem Int Ed Engl; 2020 Sep; 59(36):15595-15598. PubMed ID: 32608165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications.
    De Castro F; Stefàno E; Fanizzi FP; Di Corato R; Abdalla P; Luchetti F; Nasoni MG; Rinaldi R; Magnani M; Benedetti M; Antonelli A
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tuning the anticancer properties of Pt(ii) complexes
    Al-Rashdi KS; Babgi BA; Ali EMM; Davaasuren B; Jedidi A; Emwas AM; Alrayyani MA; Jaremko M; Humphrey MG; Hussien MA
    RSC Adv; 2022 Sep; 12(42):27582-27595. PubMed ID: 36276022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supramolecular platinum complexes for cancer therapy.
    Jogadi W; Zheng YR
    Curr Opin Chem Biol; 2023 Apr; 73():102276. PubMed ID: 36878171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel platinum(IV) complexes induce rapid tumor cell death in vitro.
    Kaludjerović GN; Miljković D; Momcilović M; Djinović VM; Mostarica Stojković M; Sabo TJ; Trajković V
    Int J Cancer; 2005 Sep; 116(3):479-86. PubMed ID: 15818622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Development of antitumor platinum complexes].
    Kidani Y
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2442-52. PubMed ID: 6360050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity.
    Nadar RA; Farbod K; der Schilden KC; Schlatt L; Crone B; Asokan N; Curci A; Brand M; Bornhaeuser M; Iafisco M; Margiotta N; Karst U; Heskamp S; Boerman OC; van den Beucken JJJP; Leeuwenburgh SCG
    Sci Rep; 2020 Apr; 10(1):5889. PubMed ID: 32246003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
    Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
    J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platinum anticancer drugs and photochemotherapeutic agents: recent advances and future developments.
    Shaili E
    Sci Prog; 2014; 97(Pt 1):20-40. PubMed ID: 24800467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.